Semaglutide, Testosterone and Sildenafil advertising on social media: The Normalisation of lifestyle enhancement drugs
Authors:
- Mikey HirstMHMikey Hirst
- Luke A. TurnockLTLuke A. Turnock
Open Access
- 19 September 2024
- journal article
- research article
- Published by Elsevier in Performance Enhancement & Health
- Vol. 12 (4)
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Getting big but not hard: A retrospective case-study of a male powerlifter's experience of steroid-induced erectile dysfunctionInternational Journal of Drug Policy, 2023
- The Liver King Lie: Misrepresentation, justification, and public health implicationsInternational Journal of Drug Policy, 2023
- Guideline-Discordant Care Among Direct-to-Consumer Testosterone Therapy PlatformsJAMA Internal Medicine, 2022
- Battling the Testosterone Clinics and WebsitesJournal of General Internal Medicine, 2022
- Social media and body image: Recent trends and future directionsCurrent Opinion in Psychology, 2022
- The pharmaceuticalisation of ‘healthy’ ageing: Testosterone enhancement for longevityInternational Journal of Drug Policy, 2021
- Testing the boundaries: Self-medicated testosterone replacement and why it is practisedInternational Journal of Drug Policy, 2021
- 2,4 dinitrophenol: It's not just for menInternational Journal of Drug Policy, 2021
- Social suppliers: Exploring the cultural contours of the performance and image enhancing drug (PIED) market among bodybuilders in the Netherlands and BelgiumInternational Journal of Drug Policy, 2017
- Social Media Effects on Young Women’s Body Image Concerns: Theoretical Perspectives and an Agenda for ResearchSex Roles, 2014